Creative Biolabs-Immuno-oncology

Anti-IGF1R (clone GFA3) SynExpress SV-Cy2-I17-E Modified CD8+ T cells (CAT#: ITS-1224-CR249)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target IGF1R (clone GFA3). We employs the HBV (SV40-Cy2-IL-17-EcoRI) vector components and the SynExpress system of the DNA methylation sites Knock-in/Positive feedback for a robust and sustained response against cancers.
Host
Human
Target
IGF1R
Clone
GFA3
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy2
Promoter
SV40
Effector Gene
IL-17
Insertion Sites
EcoRI
Gene Modification
Knock-in
Modification Domain
DNA methylation sites
Carrier Type
HBV
Transformation Accuracy
0.87
Cell Culture
Adherent Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving